. . . . . . . . . . . . . . . "tscript(p(HGNC:PPARG)) -> bp(GOBP:\"insulin receptor signaling pathway\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "PPARgamma and its ligands, the thiazolidinediones (TZD), have achieved great attention due to their insulin sensitizing and anti-inflammatory properties. Treatment with TZDs result in improved insulin signaling and increased adipose tissue influx of free fatty acids" . . "Selventa" . . . . "2014-07-03T14:32:45.724+02:00"^^ . . .